Abstract
Conclusive data to suggest a causal link between vaccination against COVID-19 (2019 coronavirus disease) and the onset of multiple sclerosis are currently missing. As of December 31, 2021, only 13 cases of relapsing-remitting multiple sclerosis coinciding with vaccination against COVID-19 have been reported. Clinical signs were observed from day 1 to 5 weeks after vaccination, with magnetic resonance imaging scans showing lesions typical of multiple sclerosis in all cases. Intravenous steroid treatment allowed for improvement in most patients. The paper presents two new case reports of patients who developed neurological symptoms shortly after vaccination against COVID-19, with additional tests and further follow-up allowing for the diagnosis of relapsing-remitting multiple sclerosis. Similar cases described in the medical literature are also presented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
